Global Blood Therapeutics Inc is a company in the U.S. stock market and it is a holding in 42 U.S.-traded ETFs. GBT has around 6.2M shares in the U.S. ETF market. The largest ETF holder of GBT is the iShares Russell 2000 ETF (IWM), with approximately 1.42M shares. Investors may also find of interest that the ETF with the largest allocation to GBT stock is Virtus LifeSci Biotech Products ETF (BBP), with a portfolio weight of 4.37%. On average, U.S. ETFs allocate 0.31% of GBT to their portfolios.
Additionally, GBT is a favorite stock for Vanilla and Active ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with GBT as a holding is the Nationwide Russell 2000 Risk-Managed Income ETF (NTKI), with a return of --.